Evidence map›Paper›PMID 29969470›Full record

ArticlePloS one2018

The duration of hypothermia affects short-term neuroprotection in a mouse model of neonatal hypoxic ischaemic injury.

Eridan Rocha-Ferreira, Amy Vincent, Sarah Bright, Donald M Peebles, Mariya Hristova

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eridan Rocha-FerreiraUCL Institute for Women's Health, Maternal & Fetal Medicine, Perinatal Brain Repair Group, London, United Kingdom.
Amy VincentUCL Institute for Women's Health, Maternal & Fetal Medicine, Perinatal Brain Repair Group, London, United Kingdom.
Sarah BrightUCL Institute for Women's Health, Maternal & Fetal Medicine, Perinatal Brain Repair Group, London, United Kingdom.
Donald M PeeblesUCL Institute for Women's Health, Maternal & Fetal Medicine, Perinatal Brain Repair Group, London, United Kingdom.
Mariya HristovaUCL Institute for Women's Health, Maternal & Fetal Medicine, Perinatal Brain Repair Group, London, United Kingdom.ORCID 0000-0002-5017-5744

Funding

Wellcome Trust WT088646MAWellcome Trust WT089624MA
6 · The paper itself

Abstract

Neonatal hypoxic-ischaemic encephalopathy (HIE) is major cause of neonatal mortality and morbidity. Therapeutic hypothermia is standard clinical care for moderate hypoxic-ischaemic (HI) brain injury, however it reduces the risk of death and disability only by 11% and 40% of the treated infants still develop disabilities. Thus it is necessary to develop supplementary therapies to complement therapeutic hypothermia in the treatment of neonatal HIE. The modified Rice-Vannucci model of HI in the neonatal mouse is well developed and widely applied with different periods of hypothermia used as neuroprotective strategy in combination with other agents. However, different studies use different periods, time of initiation and duration of hypothermia following HI, with subsequent varying degrees of neuroprotection. So far most rodent data is obtained using exposure to 5-6h of therapeutic hypothermia. Our aim was to compare the effect of exposure to three different short periods of hypothermia (1h, 1.5h and 2h) following HI insult in the postnatal day 7 C57/Bl6 mouse, and to determine the shortest period providing neuroprotection. Our data suggests that 1h and 1.5h of hypothermia delayed by 20min following a 60min exposure to 8%O2 do not prove neuroprotective. However, 2h of hypothermia significantly reduced tissue loss, TUNEL+ cell death and microglia and astroglia activation. We also observed improved functional outcome 7 days after HI. We suggest that the minimal period of cooling necessary to provide moderate short term neuroprotection and appropriate for the development and testing of combined treatment is 2h.

Indexed as

Disease Models, AnimalHypothermia, InducedNeuroprotectionNeuroprotective AgentsAnimalsAnimals, NewbornBehavior, AnimalFemaleHypoxia-Ischemia, BrainMaleMiceMice, Inbred C57BLTime FactorsNeuroprotective Agents

Identifiers

PMID29969470
PMCPMC6029790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.